Cooley-Led Life Sciences Firm Seeks To Raise $75M In IPO
A biotechnology firm developing therapies for disorders of the blood and the musculoskeletal system said Wednesday it hopes to raise about $75 million in its Cooley-led initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article